Every fact on this site, with its evidence grade, its caveats, and a link to the source.
We start you on the strong ones: findings that have been replicated or come from one large, well-controlled study. Moderate and weak facts are here too, labeled for what they are. Use “Link to this fact” to share a single card.
Laws and loopholes / Review of other studies
Product safety data sheets are written for workers, not shoppers, and only have to list hazardous ingredients present above 1% (0.1% for cancer-causing ones), a level most individual fragrance chemicals fall below.
Strong evidence: 'Most fragrance chemicals below 1%' is general formulation knowledge, not measured in this paper.
Source: Goldsmith 2014, Food and Chemical Toxicology Link to this fact
Laws and loopholes / Other evidence
A cosmetic product's fragrance-allergen labeling can legally differ between Great Britain and Northern Ireland, because Northern Ireland automatically continues to track EU cosmetics rules under the Windsor Framework (Annex 2's general alignment mechanism for placing manufactured goods on the market) while Great Britain runs its own, separately updated regime.
Strong evidence.
Caveats
Official UK government statutory guidance, updated 29 June 2026, checked directly (accessed 2026-09-28). States the general EU-alignment mechanism for NI, not a specific confirmation that any one EU amendment (such as Regulation 2023/1545) has by name reached NI.
Source: OPSS 2026 (GB/NI guidance) Link to this fact
Laws and loopholes / Other evidence
As of September 2026, Great Britain has not adopted the EU's expanded fragrance-allergen labeling list (Commission Regulation (EU) 2023/1545): the most recent identified GB amendment to the cosmetics regulation's restriction annexes (UK SI 2026/109, made 4 February 2026) addresses unrelated CMR substances, ozone, and a hexyl-salicylate concentration cap, and neither adds to the fragrance-allergen declaration list nor references Regulation 2023/1545, while Northern Ireland continues to track EU cosmetics rules generally under the Windsor Framework.
Strong evidence.
Caveats
Based on this SI's full primary text plus the GB/NI split documented in this batch's other two sources; does not rule out an allergen-list change in one of the five earlier GB cosmetics SIs (2022/659, 2023/836, 2024/455, 2024/1334, 2025/413) named in this SI's own footnote but not independently read here. GB's non-adoption is 'as of' this capture (2026-09-28), not a claim about a permanent decision; industry sources describe an OPSS consultation on alignment as only 'expected.'.
Source: UK SI 2026/109 Link to this fact
Information, not medical advice. See also: myths we won’t tell you.